BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$191.06

+1.88 (+0.99%)

As of Mar 26, 9:37 PM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 20 47%

Hold 22 51%

Sell 1 2%

Price Target

Analyst Price Target -52.1% upside

Low Target $57.23

Average Target $91.45

High Target $114.90

Current Price $191.06

Current
$191.06

Target
$91.45

$57.23 $91.45 avg $114.90

Scenario Analysis

Bear Case

$57.23

-70.0%

Low target

Base Case

$91.45

-52.1%

Avg target

Bull Case

$114.90

+-39.9%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$202.41

-5.6% from high

52-Week Low

$110.04

+73.6% from low

50-Day SMA

$179.51

+6.4% vs SMA

200-Day SMA

$150.33

+27.1% vs SMA

RSI (14)

64.3

Neutral

Target vs 52W High

$91.45

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+22.0%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+165.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.4%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.9%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-2.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.1%